World's Best Scientists 2026 revealed!
VIEW LIST
Stefan Suciu

D-Index & Metrics

Medicine

D-Index
91
Citations
30643
World Ranking
11745
National Ranking
451

Stefan Suciu publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stefan Suciu sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 416 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stefan Suciu D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan Suciu sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stefan Suciu is affiliated with the European Organisation for Research and Treatment of Cancer in the Netherlands. Their primary field of study is Medicine, with a focus on Oncology. Additional subfields of research include Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, and Molecular Biology.

Research topics covered by Stefan Suciu's work include:

  • Cutaneous Melanoma Detection and Management
  • Cancer Immunotherapy and Biomarkers
  • Acute Lymphoblastic Leukemia research
  • CAR-T cell therapy research
  • Childhood Cancer Survivors' Quality of Life
  • Melanoma and MAPK Pathways
  • Acute Myeloid Leukemia Research

Frequent coauthors collaborating with Suciu are:

  • Michal Kiciński
  • Alexander M.M. Eggermont
  • Caroline Robert
  • Christian U. Blank
  • Mario Mandalà

Publications have appeared in various scientific journals, with multiple contributions in these venues:

  • European Journal of Cancer
  • Journal of Clinical Oncology
  • The Lancet Oncology
  • American Journal of Hematology
  • JAMA Oncology

Recent papers authored or coauthored by Stefan Suciu include:

  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo, 2020, JAMA Oncology
  • Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial, 2021, The Lancet Oncology
  • Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial, 2020, Journal of Clinical Oncology
  • Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma, 2022, NEJM Evidence
  • Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial, 2021, The Lancet Oncology

Best Publications

  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Christian U. Blank;Mario Mandala;Georgina V. Long

  • Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean-Jacques Grob;Reinhard Dummer

  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

    Alexander M M Eggermont;Vanna Chiarion-Sileni;Jean Jacques Grob;Reinhard Dummer

  • Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

    R. A. Zittoun;F. Mandelli;R. Willemze;T. De Witte

  • Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

    Cavé H;van der Werff ten Bosch J;Suciu S;Guidal C

  • Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

    Alexander M. M. Eggermont;Stefan Suciu;Mario Santinami;Alessandro Testori

  • Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

    Michael Lübbert;Stefan Suciu;Liliana Baila;Björn Hans Rüter

  • Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.

    Michel Duval;Stefan Suciu;Alina Ferster;Xavier Rialland

  • On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.

    B Löwenberg;R Zittoun;H Kerkhofs;U Jehn

  • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

    Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun

  • Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy

    Fernando Ulloa-Montoya;Jamila Louahed;Benjamin Dizier;Olivier Gruselle

  • Modulation of multidrug-resistant multiple myeloma by cyclosporin

    P Sonneveld;B Lowenberg;B.G.M Durie;H.M Lokhorst

  • Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials

    Keith Wheatley;Natalie Ives;Barry Hancock;Martin Gore

  • Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

    B. Löwenberg;S. Suciu;E. Archimbaud;H. Haak

  • Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

    Sergio Amadori;Stefan Suciu;Dominik Selleslag;Franco Aversa

  • Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

    Alexander M. M. Eggermont;Stefan Suciu;Rona Mackie;Wlodzimierz Ruka

  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

    Alexander M.M. Eggermont;Michal Kicinski;Christian U. Blank;Mario Mandala

  • Expression of MAGE genes in primary and metastatic cutaneous melanoma.

    Francis Brasseur;Donata Rimoldi;Danielle Liénard;Danielle Liénard;Bernard Lethé

  • Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)

    B. Lowenberg;S. Suciu;E. Archimbaud;G.J. Ossenkoppele

  • Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Stefan Suciu;Alessandro Testori;Mario Santinami

Frequent Co-Authors

Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Theo de Witte
Theo de Witte Radboud University
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
Hélène Cavé
Hélène Cavé Université Paris Cité
Caroline Robert
Caroline Robert University of Paris-Saclay
Ulrich Keilholz
Ulrich Keilholz Charité - University Medicine Berlin
Franco Mandelli
Franco Mandelli Sapienza University of Rome
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Frédéric Baron
Frédéric Baron University of Liège
Reinhard Dummer
Reinhard Dummer University of Zurich

External Links

Personal website of Stefan Suciu

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering medical careers beyond the traditional MD route, a range of online degrees and programs can open doors to in-demand health professions. Prospective nurses can benefit from the rn to bsn online cost guide to find flexible and cost-effective pathways to advance from a registered nurse to a Bachelor of Science in Nursing. This progression can lead to better job opportunities and higher salaries.

If you do not already have a nursing background, there are direct entry nurse practitioner programs for non-nurses online available. These programs allow graduates from other fields to enter advanced practice nursing rapidly. Additionally, for those looking for accessible programs, many online bsn programs for non nurses are designed to help you start your nursing journey without traditional barriers.

For students who are interested in the healthcare industry but not in direct patient care, medical administration may be a good fit. Explore medical billing and coding financial aid programs, which provide entry into this essential and flexible field, often with financial assistance options.

Best Scientists Citing Stefan Suciu

Alexander M.M. Eggermont

Alexander M.M. Eggermont

Institut Gustave Roussy

Publications: 120

John M. Kirkwood

John M. Kirkwood

University of Pittsburgh

Publications: 99

Ching-Hon Pui

Ching-Hon Pui

St. Jude Children's Research Hospital

Publications: 88

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 84

Axel Hauschild

Axel Hauschild

Kiel University

Publications: 81

Rob Pieters

Rob Pieters

Princess Máxima Center

Publications: 80

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 76

John F. Thompson

John F. Thompson

University of Sydney

Publications: 69

Caroline Robert

Caroline Robert

University of Paris-Saclay

Publications: 68

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 68

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 67

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 65

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 62

Claus Garbe

Claus Garbe

University of Tübingen

Publications: 60

Dario Campana

Dario Campana

National University of Singapore

Publications: 60

Vernon K. Sondak

Vernon K. Sondak

University of South Florida

Publications: 59

Trending Scientists

R. L. LaMorte

R. L. LaMorte

Agricultural Research Service

Mark A. Matthews

Mark A. Matthews

University of California, Davis

Jason J. Washburn

Jason J. Washburn

Northwestern University

Jessica J. Asscher

Jessica J. Asscher

University of Amsterdam

Min Xiao

Min Xiao

University of Arkansas at Fayetteville

Rosario Moratalla

Rosario Moratalla

Spanish National Research Council

Richard T. Robertson

Richard T. Robertson

University of California, Irvine

Duilio Cascio

Duilio Cascio

University of California, Los Angeles

Andreas Karschin

Andreas Karschin

University of Würzburg

Barbara Baird

Barbara Baird

Cornell University

Lucia Margheriti

Lucia Margheriti

National Institute of Geophysics and Volcanology

Eugenia Wang

Eugenia Wang

University of Louisville

Robert E. Critoph

Robert E. Critoph

University of Warwick

D. J. Donaldson

D. J. Donaldson

University of Toronto

Marc Remke

Marc Remke

German Cancer Research Center

Lorenzo Vilizzi

Lorenzo Vilizzi

University of Łódź

Related Medicine Rankings & Guides

2026 Fastest Online Graduate Certificate Nurse Midwifery Programs

2026 Fastest Online Graduate Certificate Nurse Midwifery Programs
2026 Best Online Associate Science in Nursing (ASN) Programs

2026 Best Online Associate Science in Nursing (ASN) Programs
2026 Best Online Associate in Sonography Programs

2026 Best Online Associate in Sonography Programs
2026 Most Affordable Online Medical Assistant Programs

2026 Most Affordable Online Medical Assistant Programs
2026 Best Self-Paced Online RN-to-BSN Degree Programs

2026 Best Self-Paced Online RN-to-BSN Degree Programs
2026 Best Nurse Practitioner Programs in Illinois – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Illinois – Accredited Schools Online & Campus
2026 Best Online Associate in Health Sciences

2026 Best Online Associate in Health Sciences
2026 Fastest Online Nutrition Degree Programs

2026 Fastest Online Nutrition Degree Programs
2026 Most Affordable Healthcare Administration Degrees Online

2026 Most Affordable Healthcare Administration Degrees Online
2026 Most Affordable Online LVN Programs

2026 Most Affordable Online LVN Programs
2026 Easiest Radiology Programs to Get Into

2026 Easiest Radiology Programs to Get Into
2026 Most Affordable Online AGNP Programs

2026 Most Affordable Online AGNP Programs
2026 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs

2026 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs
2026 CMAA vs. CCMA Certification: Explaining the Difference

2026 CMAA vs. CCMA Certification: Explaining the Difference
2026 Easiest Nurse Midwife Programs to Get Into

2026 Easiest Nurse Midwife Programs to Get Into
2026 Best Online Medical Assistant Associate Degree Programs

2026 Best Online Medical Assistant Associate Degree Programs
2026 Fastest Online BSN to MSN Bridge Programs

2026 Fastest Online BSN to MSN Bridge Programs
2026 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2026 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus
2026 Fastest Online MSN in Nurse Midwifery Programs

2026 Fastest Online MSN in Nurse Midwifery Programs
2026 Best Online MSN/MBA Dual Degree Programs

2026 Best Online MSN/MBA Dual Degree Programs

Recently Published Articles

2026 Media Communication Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns

2026 Media Communication Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns
2026 How Long Does It Take to Become a Licensed Counselor?

2026 How Long Does It Take to Become a Licensed Counselor?
2026 How to Become a Health Services Manager: Salary & Career Paths?

2026 How to Become a Health Services Manager: Salary & Career Paths?
2026 Fastest Online Engineering Management Degree Programs You Can Finish in Under 2 Years

2026 Fastest Online Engineering Management Degree Programs You Can Finish in Under 2 Years
2026 Healthcare Management Career Hotspots: Cities With the Best Pay, Job Openings, and Growth

2026 Healthcare Management Career Hotspots: Cities With the Best Pay, Job Openings, and Growth
2026 Best Jobs for Criminology Majors: Salary and Responsibilities Comparison

2026 Best Jobs for Criminology Majors: Salary and Responsibilities Comparison
2026 Community Health Career Hotspots: Cities With the Best Pay, Job Openings, and Growth

2026 Community Health Career Hotspots: Cities With the Best Pay, Job Openings, and Growth
2026 Fastest Way To Become a Counselor in Arkansas

2026 Fastest Way To Become a Counselor in Arkansas
2026 Pros and Cons of Being a Medical Biller and Coder

2026 Pros and Cons of Being a Medical Biller and Coder
2026 Massachusetts MFT Licensing, Certifications, Careers and Requirements

2026 Massachusetts MFT Licensing, Certifications, Careers and Requirements
2026 Neuroscience Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns

2026 Neuroscience Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns
2026 Online Real Estate Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2026 Online Real Estate Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2026 Different Types of Healthcare Administration Degrees and Their Salaries

2026 Different Types of Healthcare Administration Degrees and Their Salaries
2026 Gender & Sexuality Studies Degree Oversupply or Undersupply? Student Volume vs Employer Demand

2026 Gender & Sexuality Studies Degree Oversupply or Undersupply? Student Volume vs Employer Demand
2026 How to Become a Mental Health Counselor in Denver, CO: Education Requirements & Certification

2026 How to Become a Mental Health Counselor in Denver, CO: Education Requirements & Certification
2026 Online Library and Information Science Degrees With the Best Tuition-to-Career Value

2026 Online Library and Information Science Degrees With the Best Tuition-to-Career Value
2026 How to Become a Preschool Teacher in Louisiana: Requirements & Certification

2026 How to Become a Preschool Teacher in Louisiana: Requirements & Certification
2026 Are There Any One-Year Online Legal Services Degree Programs Worth Considering?

2026 Are There Any One-Year Online Legal Services Degree Programs Worth Considering?
2026 Online Finance Bachelor's Degree Programs With 8-Week Classes

2026 Online Finance Bachelor's Degree Programs With 8-Week Classes
2026 How Fast Can You Get a Construction Management Degree Online?

2026 How Fast Can You Get a Construction Management Degree Online?
2026 How to Become a Pharmacologist: Education, Salary, and Job Outlook

2026 How to Become a Pharmacologist: Education, Salary, and Job Outlook